Published in Mol Cell Neurosci on February 01, 1993
A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature (1995) 2.75
BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature (1991) 2.70
The receptor for ciliary neurotrophic factor. Science (1991) 2.39
Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc Natl Acad Sci U S A (1992) 2.14
Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J Neurochem (1992) 1.85
Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med (1995) 1.70
Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol Immunol (1996) 1.67
The phosphoform of the regulatory subunit RII of cyclic AMP-dependent protein kinase possesses intrinsic topoisomerase activity. Cell (1985) 1.47
Human capillary endothelial cells from abdominal wall adipose tissue: isolation using an anti-pecam antibody. In Vitro Cell Dev Biol Anim (1995) 1.47
Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest (1995) 1.40
Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J Comp Neurol (1999) 1.36
A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. J Exp Med (1995) 1.28
TrkB mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor. Cell (1991) 1.25
K-252a and staurosporine selectively block autophosphorylation of neurotrophin receptors and neurotrophin-mediated responses. Mol Biol Cell (1992) 1.24
Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci U S A (1994) 1.22
The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J Virol (1995) 1.18
Trophic effect of ciliary neurotrophic factor on denervated skeletal muscle. Cell (1994) 1.14
Ultrastructural localization of cAMP-dependent protein kinase subunits in regenerating rat hepatocytes using immunogold electron microscopy. J Cyclic Nucleotide Protein Phosphor Res (1985) 1.13
Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J Virol (1994) 1.13
Chronic corticosterone impairs memory performance in the Barnes maze. Physiol Behav (1998) 1.10
Tumor necrosis factor-alpha: a neuromodulator in the CNS. Neurosci Biobehav Rev (1997) 1.07
Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides (1998) 1.06
The alpha-galactosyl epitope: a sugar coating that makes viruses and cells unpalatable. Cell (1996) 1.01
PPARγ activation blocks development and reduces established neuropathic pain in rats. Neuropharmacology (2013) 1.00
Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J Clin Invest (1996) 0.98
Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord. Peptides (1997) 0.97
Rapid expression of an anti-human C5 chimeric Fab utilizing a vector that replicates in COS and 293 cells. J Immunol Methods (1995) 0.96
Morphine activation of c-fos expression in rat brain. Biochem Biophys Res Commun (1988) 0.95
Localization of nuclear subunits of cyclic AMP-dependent protein kinase by the immunocolloidal gold method. J Cell Biol (1985) 0.95
Isolation of relatively large amounts of endomorphin-1 and endomorphin-2 from human brain cortex. Peptides (1997) 0.95
The neurotrophins and their receptors: structure, function, and neuropathology. Neurosci Biobehav Rev (1994) 0.94
In vitro and in vivo inhibition of complement activity by a single-chain Fv fragment recognizing human C5. Mol Immunol (1995) 0.94
Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers. Peptides (1998) 0.92
Analgesic effects of endomorphin-1 and endomorphin-2 in the formalin test in mice. Life Sci (2000) 0.92
Primate terminal complement inhibitor homologues of human CD59. Immunogenetics (1995) 0.91
Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. Eur J Pharmacol (2001) 0.90
Differential effects of endomorphin-1, endomorphin-2, and Tyr-W-MIF-1 on activation of G-proteins in SH-SY5Y human neuroblastoma membranes. Peptides (1998) 0.90
Tests used to assess the cognitive abilities of aged rats: their relation to each other and to hippocampal morphology and neurotrophin expression. Gerontology (1999) 0.90
Differential cardiorespiratory effects of endomorphin 1, endomorphin 2, DAMGO, and morphine. Am J Respir Crit Care Med (2000) 0.88
The endogenous mu-opioid receptor agonists endomorphins 1 and 2 have novel hypotensive activity in the rabbit. Biochem Biophys Res Commun (1997) 0.88
Endomorphins inhibit high-threshold Ca2+ channel currents in rodent NG108-15 cells overexpressing mu-opioid receptors. J Physiol (1998) 0.87
Protection of retroviral vector particles in human blood through complement inhibition. Hum Gene Ther (1995) 0.86
Misleading concepts in the field of brain peptides. Peptides (1984) 0.85
Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone. Brain Res (2000) 0.85
FOS expression induced by interleukin-1 or acute morphine treatment in the rat hypothalamus is attenuated by chronic exposure to morphine. Brain Res (1996) 0.85
A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex. J Immunol (1995) 0.84
Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception. Eur J Pharmacol (1999) 0.84
Nitric oxide release mediates vasodilator responses to endomorphin 1 but not nociceptin/OFQ in the hindquarters vascular bed of the rat. Peptides (1998) 0.83
In vitro demonstration of a saturable transport system for leptin across the blood-brain barrier. Life Sci (2001) 0.83
Blockade of micro-opioid receptors in the medial thalamus inhibits acquisition, but not expression, of morphine-induced conditioned place preference. Neuroscience (2007) 0.83
Mu-opioid receptor is present in dendritic targets of Endomorphin-2 axon terminals in the nuclei of the solitary tract. Neuroscience (2005) 0.83
Endomorphin 1 and 2, endogenous ligands for the mu-opioid receptor, decrease cardiac output, and total peripheral resistance in the rat. Peptides (1997) 0.83
Endomorphin 1 and 2, endogenous mu-opioid agonists, decrease systemic arterial pressure in the rat. Life Sci (1998) 0.83
Decreases in endomorphin-2-like immunoreactivity concomitant with chronic pain after nerve injury. Neuroscience (2001) 0.82
Selective transport of blood-borne interleukin-1 alpha into the posterior division of the septum of the mouse brain. Brain Res (1995) 0.82
Phe(13),Tyr(19)-melanin-concentration hormone and the blood-brain barrier: role of protein binding. J Neurochem (2000) 0.82
Fos-jun and the primary genomic response in the nervous system. Possible physiological role and pathophysiological significance. Mol Neurobiol (1991) 0.82
Topography and time course of changes in spinal neuropeptide Y immunoreactivity after spared nerve injury. Neuroscience (2009) 0.81
Periventricular penetration and disappearance of ICV Tyr-MIF-1, DAMGO, tyrosine, and albumin. Peptides (1996) 0.81
The opiate system in invertebrates. Peptides (1994) 0.81
Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59. Transplantation (1994) 0.81
Dissociation of analgesic and rewarding effects of endomorphin-1 in rats. Peptides (2000) 0.81
Prenatal stress interacts with prepuberal social isolation to reduce male copulatory behavior. Physiol Behav (1978) 0.81
The alpha9/alpha10-containing nicotinic ACh receptor is directly modulated by opioid peptides, endomorphin-1, and dynorphin B, proposed efferent cotransmitters in the inner ear. Mol Cell Neurosci (2002) 0.80
Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation. Transplantation (1995) 0.80
Saturable brain-to-blood transport of endomorphins. Exp Brain Res (2001) 0.80
Chronic exposure to morphine attenuates expression of interleukin-1 beta in the rat hippocampus. Brain Res (1996) 0.80
Interleukin-1 activation of FOS proto-oncogene protein in the rat hypothalamus. Brain Res (1993) 0.80
Anatomical and functional correlation of the endomorphins with mu opioid receptor splice variants. Eur J Neurosci (2002) 0.80
Using immunocolloidal gold electron microscopy to investigate cAMP-dependent protein kinase cellular compartmentalization. Methods Enzymol (1988) 0.80
Novel concepts from novel peptides. Ann N Y Acad Sci (1994) 0.80
Endomorphin-2 immunoreactivity in the cervical dorsal horn of the rat spinal cord at the electron microscopic level. Neuroscience (2002) 0.80
Endomorphin 1 and 2 have vasodepressor activity in the anesthetized mouse. Peptides (1998) 0.80
Humanized porcine VCAM-specific monoclonal antibodies with chimeric IgG2/G4 constant regions block human leukocyte binding to porcine endothelial cells. Mol Immunol (1997) 0.79
Neurotrophic factors, their receptors, and the signal transduction pathways they activate. Cold Spring Harb Symp Quant Biol (1990) 0.79
Minireview. Brain peptides: the dangers of constricted nomenclatures. Life Sci (1983) 0.79
Modifications induced by neonatal steroids in reproductive organs and behavior of male rats. J Comp Physiol Psychol (1979) 0.79
Neonatal peptides affect developing rats: beta-endorphin alters nociception and opiate receptors, corticotropin-releasing factor alters corticosterone. Brain Res (1986) 0.78
Morphine affects the brain-immune axis by modulating an interleukin-1 beta dependent pathway. Adv Exp Med Biol (1996) 0.78
Electron microscopic examination of the endomorphin 2-like immunoreactive neurons in the rat hypothalamus. Brain Res (2003) 0.78
The endogenous mu-opioid agonists, endomorphin 1 and 2, have vasodilator activity in the hindquarters vascular bed of the rat. Life Sci (1997) 0.78
Isolation of Tyr-W-MIF-1 from bovine hypothalami. Neuropeptides (1993) 0.78
Strategies to overcome the anti-Gal alpha (1-3)Gal reaction in xenotransplantation. Transplant Proc (1996) 0.78
Differential metabolism of Tyr-MIF-1 and MIF-1 in rat and human plasma. Biochem Pharmacol (1994) 0.77
Characterization of binding sites for N-Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in rat brain. Pharmacol Biochem Behav (1982) 0.77
Passage of interleukin-1-beta across the blood-brain barrier is reduced in aged mice: a possible mechanism for diminished fever in aging. Neuroimmunomodulation (2000) 0.77
Expression of recombinant transmembrane CD59 in paroxysmal nocturnal hemoglobinuria B cells confers resistance to human complement. Blood (1994) 0.77
Isolation of a novel peptide with a unique binding profile from human brain cortex: Tyr-K-MIF-1 (Tyr-Pro-Lys-Gly-NH2). Peptides (1994) 0.77
Endomorphin 1 and 2, the endogenous mu-opioid agonists, produce biphasic changes in systemic arterial pressure in the cat. Life Sci (1998) 0.77
Effects of peptides: a cross-listing of peptides and their central actions published in the journal Peptides from 1994 through 1998. Peptides (1999) 0.77
Melanocyte-stimulating hormone release-inhibiting factor-1 (MIF-1) can be formed from Tyr-MIF-1 in brain mitochondria but not in brain homogenate. J Neurochem (1995) 0.77
Maturation of endomorphin-2 in the dorsal horn of the medulla and spinal cord of the rat. Neuroreport (1999) 0.77
Regulation of lactate dehydrogenase gene expression by cAMP-dependent protein kinase subunits. Ann N Y Acad Sci (1986) 0.77
Retroviral vector producer cell killing in human serum is mediated by natural antibody and complement: strategies for evading the humoral immune response. Hum Gene Ther (1996) 0.77
Tyr-MIF-1, identified in brain tissue, and its analogs are active in two models of antinociception. Pharmacol Biochem Behav (1985) 0.77
Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation (1996) 0.77
Chronic treatment with morphine and ethanol, but not cocaine, attenuates IL-1 beta activation of FOS expression in the rat hypothalamic paraventricular nucleus. Adv Exp Med Biol (1995) 0.77
Peptide transport system-1 (PTS-1) for Tyr-MIF-1 and Met-enkephalin differs from the receptors for either. Brain Res (1999) 0.77
Extreme stability of Tyr-MIF-1 in CSF. Neurosci Lett (1994) 0.77